Healthcare resource utilization in a phase 3 trial of SER-109 in patients with recurrent Clostridioides difficile infection

Background: The estimated economic cost of Clostridioides difficile infection (CDI) is $5.4 billion annually, primarily attributed to acute-care costs. We previously reported data from ECOSPOR III that SER-109, an investigational oral microbiome therapeutic, was superior to placebo in reducing recur...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Stuart Cohen (Author), Thomas Louie (Author), Charles Berenson (Author), Alpesh Amin (Author), David Lombardi (Author), Sissi Pham (Author), Shirley Huang (Author), Elaine Wang (Author), Brooke Hasson (Author), Barbara McGovern (Author), Lisa Von Moltke (Author)
Format: Knjiga
Izdano: Cambridge University Press, 2022-07-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto